GE Equity

GE Equity invests globally across various sectors, focusing on established companies with high growth potential. It takes minority ownership positions and offers growth capital, buy-out co-investments, secondary direct purchases, recapitalizations, and LP investments.

Keith Miller

Senior Vice President

Ned Reynolds

Director, Media Relations - Americas

220 past transactions

Cianna Medical

Debt Financing in 2015
Cianna Medical, Inc. is a women's health company focused on developing innovative medical technologies for the treatment of early-stage breast cancer. Headquartered in Aliso Viejo, California, the company was incorporated in 2007 and is dedicated to enhancing breast conservation therapy (BCT) options for women diagnosed with breast cancer. Cianna Medical's notable products include SAVI SCOUT, a wire-free radar localization solution that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation to minimize damage to surrounding healthy tissue. Additionally, the company provides a surgical guidance system that utilizes real-time audible and visual indicators to improve precision during lumpectomy and excisional biopsy procedures. Through its advancements, Cianna Medical aims to increase access to effective treatment options for women facing breast cancer. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.

Cerapedics

Debt Financing in 2015
Cerapedics, Inc. is an orthobiologics company specializing in the development and commercialization of innovative synthetic small peptide technologies for bone healing. Founded in 2000 and headquartered in Westminster, Colorado, with an additional office in Denver, the company offers products such as i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural healing process in orthopedic applications, and i-FACTOR+ MATRIX for surgical implantation. Cerapedics focuses on creating biomimetic solutions, specifically its proprietary small peptide molecule (P-15), aimed at improving outcomes in spinal fusion surgery and other orthopedic procedures. The company's technology strives to provide safer and more predictable bone formation compared to traditional bone growth factors.

Nobilis Health

Post in 2015
Nobilis Health is a healthcare development and management company based in Houston, Texas, that specializes in owning and managing ambulatory surgical centers (ASCs) and acute-care hospitals across the United States. The company operates through two main segments: Medical Services and Marketing. Its facilities offer a wide range of surgical procedures in various specialties, including orthopedic, gastro-intestinal, gynecological, and pain management, among others. Additionally, Nobilis Health provides marketing services, patient education, and care coordination to both its facilities and third-party healthcare providers. Founded in 2007, Nobilis has experienced significant changes, including a name change from Northstar Healthcare Inc. in 2014 and a voluntary petition for liquidation under Chapter 7 in 2019. As of December 2017, the company operated 32 locations, including hospitals, ASCs, and multi-specialty clinics.

USGI Medical

Venture Round in 2015
USGI Medical specializes in developing technologies that enable surgeons to perform procedures through natural orifices, reducing the need for external incisions. Their Incisionless Operating Platform (IOP) facilitates minimally invasive surgeries, promoting faster patient recovery and minimizing scars.

GenMark Diagnostics

Post in 2015
GenMark Diagnostics, Inc. is a molecular diagnostics company headquartered in Carlsbad, California, specializing in the development and commercialization of its proprietary eSensor electrochemical detection technology. The company’s flagship XT-8 System, which has received FDA 510(k) clearance, allows for the detection of up to 72 distinct biomarkers from a single sample, producing results within 30 minutes. This system supports a variety of molecular diagnostic tests using compact workstations and self-contained, disposable test cartridges. GenMark also offers diagnostic tests for its XT-8 System, including panels for respiratory viruses, cystic fibrosis, thrombophilia risk, warfarin sensitivity, and hepatitis C virus genotyping. The company is actively developing its next-generation platform, the AD-8 System, which aims to further streamline the testing process. GenMark sells its products through direct sales and specialized service organizations across the United States and Europe.

Spiracur

Debt Financing in 2014
Spiracur Inc. is a privately held medical device company established in 2007 through the Stanford Biodesign Innovation Program. The company specializes in creating advanced wound healing technologies, with a focus on enhancing patient care. Its flagship product, the SNaP Wound Care System, was developed to address the limitations of traditional negative pressure wound therapies, which can be cumbersome for both patients and healthcare providers. The SNaP system offers a portable, non-powdered solution for chronic wound therapy, particularly benefiting diabetic patients with challenging wounds that require efficient healing. Spiracur's commitment to patient-centric design aims to improve the overall experience and outcomes in wound care management.

Schumacher Group

Debt Financing in 2014
Schumacher Group is one of the nation’s largest and fastest-growing health care resources, partnering with more than 3,000 providers to help treat more than 4 million patients annually. Our innovative, patient-centered solutions cover the entire continuum of care, including Emergency Medicine, Hospital Medicine, Care Management and Medical Billing.

CINQS

Debt Financing in 2014
CINQS, established in 2016 and headquartered in Nanterre, France, operates a smartphone application that facilitates ride-sharing. The company connects drivers with passengers seeking transportation, offering a premium private hire car service. In December 2016, CINQS was acquired by Chabé Group, a leading provider of chauffeur-driven services in Europe.

Cardiva Medical

Debt Financing in 2014
Cardiva Medical, Inc. is a medical device company based in Santa Clara, California, specializing in innovative vascular access management products that facilitate the healing process following percutaneous catheterization procedures. Founded in 2002, the company develops and markets several key products, including the VASCADE VCS, an extravascular and bioabsorbable femoral access closure system that promotes rapid hemostasis while reducing complications for patients. Additionally, Cardiva offers the Cardiva CATALYST, a manual compression assistance device that enhances coagulation and provides temporary hemostasis. The company also manufactures the VASCADE MVP, designed for multi-site venous closure in electrophysiology procedures. Cardiva Medical primarily serves physicians and cardiac centers across the United States, focusing on transforming vascular closure to benefit patients and healthcare providers.

InfoVista

Debt Financing in 2014
InfoVista provides a portfolio of software for managing 5G and next-generation networks across fixed, wireless and converged platforms. The company offers a Network Lifecycle Automation platform that supports cross-domain use cases to help service providers and enterprise organizations holistically monitor, operate, and optimize infrastructure, services, and applications while ensuring availability and quality of service. InfoVista's tools cover planning, operation, optimization, and monetization of networks, delivering network intelligence across the entire lifecycle and enabling clients to gain real-time insights to inform business decisions.

USGI Medical

Debt Financing in 2014
USGI Medical specializes in developing technologies that enable surgeons to perform procedures through natural orifices, reducing the need for external incisions. Their Incisionless Operating Platform (IOP) facilitates minimally invasive surgeries, promoting faster patient recovery and minimizing scars.

SINTX Technologies

Post in 2014
SINTX Technologies is a ceramics company focused on silicon nitride for medical and related applications. It develops and manufactures silicon nitride biomaterials used in implants and devices, with products designed to be biocompatible, bioactive, antipathogenic, and to have good bone affinity. The company produces silicon nitride spinal implants in an ISO 13485 certified facility for CTL-Amedica, its exclusive retail channel for such implants, and markets products through direct sales, distributors, OEM partnerships, and private-label arrangements. Founded in 1996 and headquartered in Salt Lake City, it serves customers in the United States, Europe, and South America.

Cianna Medical

Debt Financing in 2014
Cianna Medical, Inc. is a women's health company focused on developing innovative medical technologies for the treatment of early-stage breast cancer. Headquartered in Aliso Viejo, California, the company was incorporated in 2007 and is dedicated to enhancing breast conservation therapy (BCT) options for women diagnosed with breast cancer. Cianna Medical's notable products include SAVI SCOUT, a wire-free radar localization solution that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation to minimize damage to surrounding healthy tissue. Additionally, the company provides a surgical guidance system that utilizes real-time audible and visual indicators to improve precision during lumpectomy and excisional biopsy procedures. Through its advancements, Cianna Medical aims to increase access to effective treatment options for women facing breast cancer. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.

Del Taco

Debt Financing in 2014
Del Taco is a restaurant chain offering a blend of Mexican-inspired and American classic dishes. All menu items are prepared to order using fresh ingredients, including handmade pico de gallo salsa, slow-cooked beans, and marinated chicken. The menu features tacos, burritos, quesadillas, hamburgers, fries, shakes, and a breakfast menu.

Cerapedics

Debt Financing in 2014
Cerapedics, Inc. is an orthobiologics company specializing in the development and commercialization of innovative synthetic small peptide technologies for bone healing. Founded in 2000 and headquartered in Westminster, Colorado, with an additional office in Denver, the company offers products such as i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural healing process in orthopedic applications, and i-FACTOR+ MATRIX for surgical implantation. Cerapedics focuses on creating biomimetic solutions, specifically its proprietary small peptide molecule (P-15), aimed at improving outcomes in spinal fusion surgery and other orthopedic procedures. The company's technology strives to provide safer and more predictable bone formation compared to traditional bone growth factors.

AirXpanders

Debt Financing in 2014
AirXpanders, Inc. was a medical device company headquartered in San Jose, California, specializing in the design, manufacture, sale, and distribution of innovative medical devices aimed at improving breast reconstruction outcomes. Founded in 2005, the company developed the AeroForm Tissue Expander System, a needle-free and patient-controlled device specifically designed for use in two-stage breast reconstruction following mastectomy. This system allowed patients to expand tissue in a controlled manner before the insertion of breast implants. Despite its advancements in medical technology, AirXpanders filed for Chapter 7 bankruptcy and ceased operations on September 25, 2019.

SynGen

Series C in 2014
SynGen Inc. is a biotechnology company that specializes in the development, design, and manufacturing of innovative cell separation tools and accessories aimed at the recovery of target cells while depleting contaminating cells. Founded in 2007 and headquartered in Sacramento, California, with an additional location in Runcorn, United Kingdom, SynGen offers a range of medical devices, including the SynGenX-1000 and SynGenX-2000 Systems, which are closed sterile processing systems designed for the isolation of stem and progenitor cells and the preparation of platelet-rich plasma, respectively. The company also provides laboratory solutions such as the SynGenX-Lab System for cell extraction and the CryoPRO Workstation for cryopreservation. Additionally, SynGen develops software like SynGen DataTrak for data management in clinical and manufacturing environments. Its products are utilized in diagnostic, research, and clinical processes, contributing significantly to the field of regenerative medicine.

Tangent Medical Technologies

Debt Financing in 2014
Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath™ Closed IV Catheter System, in 2012.

WKS Restaurant Group

Debt Financing in 2014
WKS Restaurant Corporation is a prominent franchisee in the United States, primarily operating multiple restaurant brands including El Pollo Loco, Wendy's, Denny's, Krispy Kreme Doughnuts, and Corner Bakery Cafe. Founded in 1987 and headquartered in Lakewood, California, the company has expanded its operations across California, Arizona, Denver, and El Paso. WKS Restaurant Corporation also emphasizes management training programs to ensure effective hiring and operational excellence within its franchise locations.

Chromatin

Series E in 2014
Chromatin is a biotech company focused on developing and marketing innovative technologies and products across agricultural, energy, chemical, nutritional, and pharmaceutical sectors. The company specializes in hybrid, drought-tolerant sorghum seeds, utilizing advanced breeding methodologies to create next-generation sorghum that meets the rising demand for sustainable agricultural practices. By combining diverse sorghum varieties, Chromatin produces seeds that can thrive on more than 80% of the world's agricultural land, supporting farmers in optimizing crop production for both traditional agriculture and bio-industrial applications. The company aims to address key societal challenges, enhancing agricultural productivity and contributing to renewable energy resources.

RadioShack

Venture Round in 2013
RadioShack is a retailer of electronics goods serving consumers through a large network of company-owned stores in the United States and an online platform. It offers a broad range of products, including headphones, radios, batteries, and other accessories, providing affordable options for personal and home technology. The company positions itself as a neighborhood technology resource supported by knowledgeable associates who help customers select and apply products. Its curated assortment covers personal and home tech, power supplies, mobility, music, audio, and digital fitness devices, enabling shoppers to find tools that fit their lifestyle. RadioShack emphasizes collaborative and hands-on assistance to bring technology ideas to life, combining physical locations with digital shopping to reach a wide audience and deliver a trusted, approachable tech retail experience.

Drive Medical

Debt Financing in 2013
Drive Medical is one of the fastest growing global distributors of durable medical equipment. The Company markets and distributes its products to customers located throughout North America, Europe, Central America, South America, the Middle East and Asia. Drive has corporate offices and distribution facilities located throughout the United States, Canada, the United Kingdom, Germany, Romania, China and Taiwan. Drive North America Technical Service Center is located in Bohemia, New York. See the "Contact Us" section for all location details. Drive was formed in January 2000 under the name Medical Depot, Inc. Not long after the Company started, the ownership recognized the opportunity to reflect the spirit of the Company and the quality of life it provides to the users of their products, and therefore, changed the name to Drive. This culture and drive led to the significant growth and the formation of a multi-national organization. The continuous growth and expansion is supported by the best professionals in the business, state-of-the-art technology and an undying winning attitude.

Sonitus Medical

Debt Financing in 2013
Sonitus Medical Inc. is a privately held medical device company based in San Mateo, California, focused on delivering innovative hearing solutions for patients with hearing challenges. The company specializes in bone conduction hearing devices and markets the SoundBite Hearing System, which is recognized as the world's first non-invasive and removable hearing solution that transmits sound through the teeth. This nearly invisible in-the-mouth hearing system is designed to address single-sided deafness and conductive hearing loss, providing a simple and non-surgical alternative for patients. The device is currently FDA cleared as a prosthetic for these specific conditions. Sonitus Medical aims to expand its technology to include treatments for mixed hearing loss and tinnitus, as well as applications in consumer and covert communications. Founded in 2006, Sonitus Medical is emerging as a leader in the field of hearing solutions.

Xand

Debt Financing in 2013
Xand is a facilities-based provider specializing in data center managed services and technology solutions tailored for clients with critical operational needs. Established in 1999, the company has built a reputation for designing, constructing, and managing IT infrastructure that enhances the performance and availability of vital applications. Xand offers a range of services including colocation, cloud solutions, enterprise hosting, managed services, and business continuity/disaster recovery, catering to various industries such as education, manufacturing, healthcare, retail, and finance. With a focus on mitigating risks associated with single facilities, Xand operates six data centers, ensuring robust backup and support. The company's commitment to superior engineering and customer service enables clients to improve business performance while effectively managing risk.

Karro Food Group

Private Equity Round in 2013
Karro Food Group, headquartered in Malton, North Yorkshire, is a prominent producer of a wide range of pork products, including bacon, gammon, fresh pork, frozen sausage, ham, and cooked meats. The company processes approximately 45,000 pigs weekly, supplying high-quality meat to retail, food service, and manufacturing customers throughout the UK. With operations across various locations in England, Scotland, and Northern Ireland, Karro ensures full supply chain visibility for its products, which are available in major supermarkets and wholesale food suppliers. Employing around 3,000 individuals, Karro Food Group plays a significant role in the UK meat industry, providing pork consumed by millions of consumers annually.

Skylight Healthcare Systems

Debt Financing in 2013
Skylight Healthcare Systems, Inc. specializes in providing interactive patient care system technology for hospitals and healthcare administrators. The company operates the ACCESS interactive patient system, a two-way digital communications platform that transforms hospital television sets into comprehensive information, communication, education, and entertainment networks. This system enables patients to access essential information about their hospital stay, request assistance from support departments, view on-demand health education, provide real-time feedback through surveys, and enjoy various entertainment options. Additionally, Skylight offers iCarePassport, a web-based patient care and outcomes system designed to enhance ongoing patient engagement by facilitating personalized communication throughout the continuum of care. Founded in 1999 and headquartered in San Diego, California, Skylight Healthcare Systems addresses the critical needs of patients in education, health literacy, and access to services, thereby improving the overall healthcare experience.

Plus Therapeutics

Post in 2013
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Austin, Texas, dedicated to the discovery, development, and manufacturing of innovative treatments for cancer and rare diseases. The company's lead product candidate, DocePLUS, is a protein-stabilized PEGylated liposomal formulation of docetaxel aimed at treating small cell lung cancer. Additionally, Plus Therapeutics is developing DoxoPLUS, a formulation of doxorubicin intended for breast and ovarian cancer, multiple myeloma, and Kaposi’s sarcoma. The company is also engaged in developing therapies for central nervous system cancers, including recurrent glioblastoma and leptomeningeal metastases, with a key candidate being rhenium (186Re) obisbemeda. Plus Therapeutics leverages proprietary nanotechnology to enhance drug delivery and efficacy while minimizing side effects. Founded in 1996, the company was previously known as Cytori Therapeutics, Inc. before rebranding in July 2019.

View

Series E in 2013
View, Inc., established in 2006 and headquartered in Milpitas, California, specializes in designing and manufacturing intelligent glass systems for various sectors, including workplace, healthcare, education, and hospitality. The company's flagship product, View Smart Windows, employs AI to automatically adjust in response to sunlight, enhancing natural light access and occupant experience, while minimizing heat and glare, and reducing energy consumption. Each View installation also includes a cloud-connected smart building platform, enabling further building optimization. With operations in the U.S. and internationally, View has improved over 90 million square feet of buildings, ranging from offices to multifamily residences.

ASI System Integration

Debt Financing in 2013
ASI System Integration, Inc. is North America’s leading independent provider of IT services and solutions.

SINTX Technologies

Debt Financing in 2013
SINTX Technologies is a ceramics company focused on silicon nitride for medical and related applications. It develops and manufactures silicon nitride biomaterials used in implants and devices, with products designed to be biocompatible, bioactive, antipathogenic, and to have good bone affinity. The company produces silicon nitride spinal implants in an ISO 13485 certified facility for CTL-Amedica, its exclusive retail channel for such implants, and markets products through direct sales, distributors, OEM partnerships, and private-label arrangements. Founded in 1996 and headquartered in Salt Lake City, it serves customers in the United States, Europe, and South America.

Mayborn Group

Debt Financing in 2013
Mayborn Group specializes in manufacturing and distributing a range of products for infants and babies. Their primary brand is Tommy Tippee, known for feeding bottles and soothing products. They also offer hygiene items such as diaper bins and baby monitors.

CardioDx

Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Hospedia

Venture Round in 2012
Hospedia is a UK-based provider of point-of-care systems and clinical support software that enhances the patient experience in healthcare settings. With a strong presence in the acute National Health Service (NHS) sector, the company holds a 75% market share, supplying bedside terminals to over 150 hospitals. These terminals cater to approximately 10 million patients, 5 million visitors, and 500,000 healthcare professionals annually. Hospedia's platform facilitates bedside communication and multimedia services, ensuring patients are both educated and entertained throughout their healthcare journey. This technological integration supports healthcare professionals by providing real-time information, ultimately enabling quicker and safer decision-making in clinical environments.

CardioDx

Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

C8 MediSensors

Series C in 2012
C8 MediSensors, Inc., a San Jose, CA-based developer of non-invasive continuous glucose monitors for diabetic patients.

Redapt

Venture Round in 2012
Redapt is a comprehensive systems integrator specializing in innovative data center infrastructure and cloud solutions. It caters to businesses of all sizes, helping them optimize IT costs and enhance value while allowing their technical teams to focus on core business activities.

BG Medicine

Post in 2012
BG Medicine, Inc. is a life sciences company dedicated to the development and commercialization of diagnostic products aimed at assisting patients with heart failure and related disorders in the United States. The company offers the BGM Galectin-3 Test, an in vitro diagnostic device that quantifies galectin-3 levels in serum or plasma using an enzyme-linked immunosorbent assay on a microtiter plate platform. Additionally, BG Medicine provides the CardioSCORE Test, a multi-analyte biomarker-based blood test that evaluates the near-term risk of atherothrombotic cardiovascular events, including heart attacks and ischemic strokes. The company has established licensing and commercialization agreements with various healthcare organizations for automated versions of its galectin-3 test. Founded in 2000 and headquartered in Waltham, Massachusetts, BG Medicine was previously known as Beyond Genomics, Inc. before changing its name in 2004.

MedShape

Debt Financing in 2012
MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.

Infraredx

Debt Financing in 2011
Infraredx, Inc. is a cardiovascular imaging medical device company focused on the diagnosis and treatment of coronary artery diseases. Founded in 1998 and headquartered in Burlington, Massachusetts, Infraredx specializes in near-infrared spectroscopy technology and its application in coronary imaging. The company develops and manufactures advanced imaging systems, including a dual-modality near-infrared spectroscopy intravascular ultrasound system, which allows for the identification of lipid core coronary plaques and provides structural information about plaque. Its product lineup also features the Makoto intravascular imaging system, the Dualpro catheter that combines intravascular ultrasound and near-infrared spectroscopy, and optical catheters for high-resolution imaging of plaque structures. Infraredx serves hospital sites across the United States and Europe and has been operating as a subsidiary of Goodman USA, Inc. since 2015.

SolarEdge Technologies

Venture Round in 2011
Founded in 2006, SolarEdge specializes in module-level electronics for solar power harvesting and monitoring systems. Its portfolio includes DC power optimizers, inverters, and a cloud-based monitoring platform, serving residential, commercial, and utility-scale solar markets worldwide.

Eurofactor

Acquisition in 2011
Eurofactor is a UK-based company specializing in credit services, including invoice discounting, invoice factoring, and asset-based lending. The firm also engages in debt collection by purchasing outstanding debts from businesses. In addition to these services, Eurofactor offers credit information and facilitates the collection of overseas payments, helping businesses manage their cash flow and reduce financial risk. Through its comprehensive range of services, Eurofactor aims to support companies in optimizing their financial operations and improving liquidity.

MCCI Medical Group

Private Equity Round in 2011
MCCI is a physician group that has expanded over the years from their origin as practicing physicians. They analyzed their ways of doing things and found ways to improve them. It has increased their attention to our patients, and has thereby improved our product and goal—their patients health. They have applied this model and have successfully grown to a group including over 100 Primary Care Physicians and 200 Affiliated Specialists.

Saladax Biomedical

Debt Financing in 2011
Saladax Biomedical, Inc. is a precision medicine company based in Bethlehem, Pennsylvania, focused on developing and commercializing diagnostic blood tests that enhance personalized medicine. The company offers a range of products aimed at optimizing drug therapy in psychiatry and oncology. Its MyCare product line includes tests such as MyCare Psychiatry, which helps determine appropriate antipsychotic dosages; MyCare Oncology, which focuses on chemotherapy exposure optimization; and MyCare Neurology for assessing neurological drug effects. Key tests include My5-FU, MyPaclitaxel, MyDocetaxel, and MyImatinib, which are designed to tailor chemotherapy treatments for various cancers. Saladax Biomedical markets its diagnostic solutions to healthcare providers worldwide through both distributors and direct sales, striving to empower physicians to deliver personalized care by ensuring optimal drug dosing. The company has been providing innovative diagnostic solutions for over 15 years.

Huaneng Renewables

Post in 2011
Huaneng Renewables Corporation Limited is a prominent Chinese company focused on the co-development of renewable energy projects, particularly in wind and solar energy. Established in November 2002, it operates ten wind power plants recognized with national quality awards. The company has developed six wind power bases across various regions, including Northeast China and Sinkiang, and has pioneered significant advancements in the sector, such as establishing the first domestic wind testing fields and large-scale wind-and-solar complementary sites. Huaneng Renewables primarily invests in, constructs, acquires, and operates renewable energy projects throughout China, generating most of its revenue from electricity sales produced by its wind and solar power facilities. As a wholly-owned subsidiary of Huaneng Group, one of China's largest state-owned electric utility companies, Huaneng Renewables plays a vital role in the country’s transition toward sustainable energy sources.

CardioDx

Private Equity Round in 2011
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Datapipe

Debt Financing in 2011
Datapipe is a provider of managed hosting, cloud services, and data center solutions designed to manage and secure mission-critical IT services. The company offers a comprehensive range of services, including cloud computing, infrastructure as a service, platform as a service, colocation, business analytics, database management, e-commerce hosting, email hosting, and data protection. Datapipe serves a diverse array of industries, such as financial services, healthcare, manufacturing, government, and media, enabling clients to optimize both critical and everyday IT operations. With a presence in major global markets, including New York, Silicon Valley, London, Hong Kong, and Shanghai, Datapipe has established itself as a significant player in the technology landscape. The company was recognized in Gartner's Magic Quadrant for Cloud Infrastructure as a Service and Web Hosting in 2010, highlighting its commitment to delivering high-quality services.

NeoVista

Debt Financing in 2011
NeoVista Inc is focused on developing medical technologies aimed at improving the treatment of wet age-related macular degeneration (AMD), a condition that affects over 5 million people globally and is a leading cause of blindness among individuals over the age of 50. The company is engaged in clinical studies to validate its innovative technology, which shows promise in enhancing patient care and alleviating the challenges posed by this debilitating condition for both patients and healthcare providers. Through its efforts, NeoVista aims to significantly impact the quality of life for those affected by wet AMD.

eBioscience

Venture Round in 2011
eBioscience is a global leader in immunology and oncology flow cytometry reagents. It offers one of the world's largest selections of antibodies, ELISAs, and proteins for life science research and diagnostics.

CareDx

Grant in 2011
CareDx is a molecular diagnostics company specializing in noninvasive surveillance tests to identify post-transplant injuries and rule out rejection, supporting the entire transplant journey from initial matching to patient care.

Loehmann's

Venture Round in 2009
Founded in 1921, Loehmann's is a New York-based off-price retailer specializing in designer fashions for women, men, juniors, and children. It offers a wide range of products including sportswear, dresses, accessories, handbags, jewelry, and shoes across multiple store locations in the United States.

TPI Composites

Series B in 2009
TPI Composites, Inc. is a manufacturer specializing in composite wind blades and related precision molding and assembly systems, primarily for original equipment manufacturers. Founded in 1968 and headquartered in Scottsdale, Arizona, the company serves multiple industries, including wind energy and transportation, where it produces large-scale composite structures for applications such as buses, rail systems, and military vehicles. TPI operates factories across the United States, Mexico, and Asia, with a significant portion of its revenue coming from operations in Mexico. The company is known for its innovative technology that emphasizes high strength, lightweight, and durability in its products.

Calypso Soft Drinks

Venture Round in 2009
They have been in the business for over 125 years, building a reputation in the UK for exceptional quality and customer satisfaction and we pride ourselves on the range that they offer. Most of their drinks are packed full of pure fruit juice like their Aquajuice range, so count as one of your five-a-day and they’re proud to say that a lot of their products are school approved. This means that children up and down the country can choose a healthy drink with their School dinner every day.

Micell Technologies

Series B in 2009
Micell Technologies, Inc. is a biomedical device company specializing in interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in Raleigh, North Carolina, the company develops innovative products such as the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System, which combines the benefits of a drug-eluting stent with those of a bare-metal stent. Micell also offers drug-coated balloons that deliver sirolimus to the artery wall during procedures like percutaneous transluminal angioplasty, as well as bioresorbable scaffolds for controlled drug delivery. Utilizing advanced technologies, Micell aims to enhance healing and improve clinical outcomes in the treatment of cardiovascular diseases. Additionally, the company provides clinical trials and health economics services to support its product development and market strategies.

SunGard

Debt Financing in 2009
SunGard Data Systems Inc. is a global provider of software and technology services, primarily serving the financial services, education, and public sectors. The company operates through four segments: Financial Systems, Higher Education, Public Sector, and Availability Services. The Financial Systems segment offers solutions that automate processes related to trading, investment portfolio management, and asset accounting, catering to financial institutions, corporate treasury departments, and energy companies. The Higher Education segment provides enterprise resource planning and administrative solutions for colleges and universities, addressing their academic and operational needs. The Public Sector segment focuses on software and services for K-12 education, government agencies, and public institutions, supporting various administrative functions and public safety initiatives. The Availability Services segment ensures uninterrupted access to critical IT systems through recovery and managed services. SunGard offers its solutions through traditional software and cloud-based models, emphasizing technology consulting and implementation services. Founded in 1983 and based in Wayne, Pennsylvania, SunGard Data Systems Inc. operates as a subsidiary of SunGard Holdco LLC.

SecureWorks

Series C in 2009
SecureWorks specializes in managed security services, offering network and IT security solutions. Recognized by Gartner as a leader in its Magic Quadrant for MSSPs, SecureWorks' platform combines SIEM with applied research and GIAC-certified experts to protect clients from cyber threats.

SolarEdge Technologies

Series B in 2009
Founded in 2006, SolarEdge specializes in module-level electronics for solar power harvesting and monitoring systems. Its portfolio includes DC power optimizers, inverters, and a cloud-based monitoring platform, serving residential, commercial, and utility-scale solar markets worldwide.

KSK Power Venture

Private Equity Round in 2008
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.

Grid Net

Series B in 2008
Grid Net is a software company that specializes in providing solutions for the smart grid, focusing on utility customers and technology partners. The company's Machine-to-Machine Network Operating System is designed to efficiently manage grid devices and advanced applications across various network types, including public and private, wired and wireless. By emphasizing strategic deployments of high-value grid applications, Grid Net aims to deliver immediate returns and sustainable value for its clients. The company is headquartered in San Francisco, California, with additional offices in Sydney, Melbourne, and Tokyo. Grid Net is supported by prominent investors, including Intel Capital and Cisco Systems, which reinforces its position in the smart grid sector.

Mzinga

Series D in 2008
Mzinga, Inc. specializes in providing enterprise social software solutions and services tailored for learning, marketing, and support sectors. The company offers a suite of products, including OmniSocial Learning, which fosters a collaborative social business ecosystem for enhanced learning and communication, and the OmniSocial Learning Extended Enterprise, aimed at customer acquisition and support. Mzinga also features the Learning Record Store, which facilitates tracking and reporting of user interactions, and Composica, a platform for collaborative e-learning content creation. Founded in 1986 and headquartered in Burlington, Massachusetts, Mzinga serves over 14,000 communities, facilitating approximately 2.5 billion monthly social interactions from 40 million unique visitors across 160 countries. The company's solutions are designed to improve business performance by enhancing brand visibility, workplace satisfaction, and customer loyalty.

Archus Orthopedics

Venture Round in 2008
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.

InSightec

Venture Round in 2007
InSightec Ltd. is a pioneering company based in Tirat Carmel, Israel, specializing in non-invasive medical treatments through its Exablate platform, which employs MR guided focused ultrasound technology. Founded in 1999, InSightec develops and distributes systems that address various oncology and gynecology conditions, including the Exablate Neuro for personalized thalamotomy in movement disorders and pain management. The Exablate system has received multiple regulatory approvals, including CE marks and FDA approval, for treatments of symptomatic uterine fibroids, pain from bone metastases, and adenomyosis. The company provides comprehensive support services, including onsite clinical training and maintenance, to medical professionals using its technology in facilities across Israel and internationally. InSightec maintains a strategic partnership with Lantheus Holdings and has expanded its presence in Europe, Asia, and the Americas, earning recognition for its innovative contributions to the field of acoustic surgery.

KSK Power Venture

Post in 2007
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.

Vivid Restaurant Concepts

Venture Round in 2007
Vivid Restaurant Concepts is a restaurant operator based in the United States, overseeing a chain of dining establishments. The company focuses on providing a diverse array of cuisines, catering to a broad spectrum of customer preferences. By maintaining high standards in food quality and service, Vivid Restaurant Concepts aims to create memorable dining experiences for its patrons while expanding its presence in the competitive restaurant industry.

Micell Technologies

Series A in 2007
Micell Technologies, Inc. is a biomedical device company specializing in interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in Raleigh, North Carolina, the company develops innovative products such as the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System, which combines the benefits of a drug-eluting stent with those of a bare-metal stent. Micell also offers drug-coated balloons that deliver sirolimus to the artery wall during procedures like percutaneous transluminal angioplasty, as well as bioresorbable scaffolds for controlled drug delivery. Utilizing advanced technologies, Micell aims to enhance healing and improve clinical outcomes in the treatment of cardiovascular diseases. Additionally, the company provides clinical trials and health economics services to support its product development and market strategies.

A123 Systems

Series C in 2007
A123 Systems is a manufacturer of rechargeable lithium-ion batteries and battery systems, specializing in efficient power supply solutions for electronic devices. The company leverages advanced nanoscale materials, particularly its proprietary Nanophosphate electrode technology, which offers significant advantages in performance and cost. A123's cell and electrode designs result in lower costs per watt and watt-hour, while providing higher voltage compared to traditional long-life systems. This technology also contributes to a longer battery life, reducing overall lifecycle and system costs, thereby enhancing price-performance for clients. A123 Systems competes with other industry players such as Valence, Saft, and Lion Cells.

Brightcove

Series B in 2006
Brightcove, established in 2004, is a global video technology company that empowers businesses to deliver professional video experiences across various connected devices. It offers cloud-based solutions for video delivery and monetization, serving a wide range of industries, including media, broadcasting, digital publishing, and retail, among others. Brightcove's flagship product, Video Cloud, enables customers to publish and distribute video content through a subscription-based SaaS model. The company is renowned for its innovative technology, exceptional customer support, and global infrastructure, helping organizations worldwide leverage the power of video to engage audiences.

LipoScience

Series F in 2006
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

Carmen Systems

Venture Round in 2006
Carmen Systems develops, markets and implements resource optimization solutions for clients found primarily in the transportation industry. Carmen Systems’ software solutions improve our clients’ productivity and bottom-line profitability. Our solutions combine the latest in research and technology and include analysis, simulation, development and implementation. Of approximately 290 employees from 32 nationalities, around one third work with R&D, of these 12 per cent have a PhD. Collaboration with a number of leading universities in different countries further contributes to Carmen Systems’ strength in the field of resource optimization. The company headquarters is in Göteborg, Sweden with offices in Amsterdam, Austin (Texas), Brisbane (Australia), Copenhagen, London, Madrid, Monterrey (Mexico), Montreal, Paris, Singapore and Stockholm. Carmen Systems is owned by its management and employees, GE Commercial Finance, Gilde IT Fund B.V., and InnovationsKapital.

Singulex

Series C in 2006
Singulex develops and commercializes single molecule counting technology for clinical diagnostics and scientific discovery. Its flagship product, the Sgx Clarity System, enables ultra-sensitive detection of biomarkers down to femtograms/mL, aiding in cardiovascular health management and personalized wellness programs. Singulex serves pharmaceutical R&D labs, clinical research organizations, and academic institutions worldwide.

A123 Systems

Series B in 2006
A123 Systems is a manufacturer of rechargeable lithium-ion batteries and battery systems, specializing in efficient power supply solutions for electronic devices. The company leverages advanced nanoscale materials, particularly its proprietary Nanophosphate electrode technology, which offers significant advantages in performance and cost. A123's cell and electrode designs result in lower costs per watt and watt-hour, while providing higher voltage compared to traditional long-life systems. This technology also contributes to a longer battery life, reducing overall lifecycle and system costs, thereby enhancing price-performance for clients. A123 Systems competes with other industry players such as Valence, Saft, and Lion Cells.

RPO

Series B in 2006
RPO, Inc. develops, designs, and manufactures waveguides for the consumer electronics market. The company’s products include digital waveguide touch systems, which is a touch screen solution applied in various products, including gameplayers, cellphones, PDAs, GPS systems, automotive control displays, multimedia players, and tablet personal computers, as well as in ATM’s and gambling machines. It also manufactures polymer optical waveguides on wafer and panel substrates. The company was incorporated in 2005 and is headquartered in San Jose, California. It has a research and development facility in Canberra, Australia; and pilot assembly operations in Sydney, Australia.

Univa

Venture Round in 2005
Univa Corporation, founded in 2004 and based in Hoffman Estates, Illinois, specializes in enterprise-class workload management and containerization solutions. The company offers a range of products, including Univa Grid Engine, a distributed resource management system designed to optimize data center resources. Its offerings also feature various add-ons such as Container Edition, which enhances the efficiency of Docker containers; Short Jobs, which enables rapid task execution; and License Orchestrator for managing licensed application features across clusters. Additionally, Univa provides the Universal Resource Broker for hosting big data frameworks, UniSight Reporting for usage analytics, UniCloud for leveraging cloud resources, and Navops, a cloud-automation platform. These solutions empower organizations to manage and optimize applications, containers, and data center services effectively. Univa operates additional offices in Markham, Canada, and Munich and Regensburg, Germany, and it is a subsidiary of Altair Engineering Inc.

Redfern Integrated Optics

Series C in 2005
Redfern Integrated Optics develops and manufactures optical transmitters based on proprietary PLANEX (Planar External Cavity Laser) technology, which enables high performance at low cost for various applications. RIO planar ECL consists of a gain chip and a planar waveguide circuit (PLC) with Bragg grating which forms a laser cavity. This has significant advantages such as; very narrow spectral linewidth, low phase noise and RIN, optimized chirp, low wavelength sensitivity to temperature and bias current, and low power consumption.

OutlookSoft

Series D in 2005
OutlookSoft is a provider of business planning and performance management solutions, specializing in predictive performance management. Founded in 1999 and headquartered in Stamford, Connecticut, the company offers a comprehensive platform that facilitates strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to ensure effective utilization of its products. Its offerings cater to a wide array of industries, including manufacturing, financial services, and the public sector, enabling organizations to effectively measure, manage, and predict their financial and operational performance. The company also maintains offices in the United Kingdom, France, Switzerland, and Italy.

Speed Commerce

Post in 2005
Speed Commerce, Inc. is a provider of comprehensive e-commerce and fulfillment services for retailers and manufacturers across the United States and Canada. Established in 1983 and headquartered in Richardson, Texas, the company offers a range of services including web platform development, order management, fulfillment, logistics, and contact center support. These services are designed to deliver transaction-based solutions and information management tools tailored to client needs. Speed Commerce operates fulfillment centers in Pennsylvania, Ohio, Missouri, and Texas, employing advanced automation technologies such as unit sortation and RF scanning to enhance efficiency. The company, which rebranded from Navarre Corporation in 2013, focuses on delivering flexible solutions and high-quality services to help its clients grow their businesses.

Iridian Technologies

Series C in 2005
Iridian Technologies, founded in 1990 and headquartered in Moorestown, New Jersey, specializes in the research, development, and marketing of biometric identifiers. The company offers PrivateID, an image processing protocol enabling secure iris recognition, and KnoWho, an authentication server for identity verification. Their products cater to public-use applications like border control and restricted access systems, distributed through integrators and application partners. Prior to its acquisition by Viisage Technology Inc. in 2006, the company operated under the name IriScan, Inc., changing its moniker to Iridian Technologies in 2000.

CiCi's Pizza

Venture Round in 2005
CiCi's Pizza began in 1985 with a single restaurant in Plano, Texas, and has since expanded to over 450 locations across 32 states. The company is known for pioneering the unlimited pizza buffet concept, allowing customers to enjoy a diverse selection of pizzas, including traditional crust and flatbreads, as well as pasta, salads, and desserts. This business model caters to a variety of tastes, enabling guests to explore and enjoy different flavors of Italian cuisine in a casual dining setting. CiCi's Pizza emphasizes customer satisfaction by encouraging patrons to personalize their dining experience.

WIS International

Corporate Round in 2004
WIS International Ltd. is a provider of inventory and data collection services, catering to retailers and various sectors worldwide, including healthcare, manufacturing, and logistics. Founded in 1967 and based in Mississauga, Canada, with additional locations in San Diego, California, and Flower Mound, Texas, the company offers a range of services such as physical inventory counting, inventory consulting, information management, and merchandising. WIS International specializes in optimizing inventory processes, enhancing accuracy, and reducing costs for its clients through innovative technology solutions. The company was previously known as Western Inventory Service Ltd. before rebranding in April 2005.

AGY Therapeutics

Series C in 2004
AGY Therapeutics is a biopharmaceutical company based in South San Francisco, California, founded in 1998. The company specializes in discovering, developing, and commercializing treatments for diseases of the central nervous system (CNS). Its focus areas include neurodegenerative diseases, CNS injuries, stroke, cognitive diseases, and schizophrenia. AGY Therapeutics has a pipeline of novel therapeutic programs, both in clinical and preclinical development, aimed at addressing significant unmet medical needs. The company uses its proprietary platform for functional gene discovery and mapping specific pathways underlying CNS diseases to identify potential target proteins that can modulate disease progression. This approach is designed to pave the way for innovative CNS therapeutics.

OutlookSoft

Series D in 2004
OutlookSoft is a provider of business planning and performance management solutions, specializing in predictive performance management. Founded in 1999 and headquartered in Stamford, Connecticut, the company offers a comprehensive platform that facilitates strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to ensure effective utilization of its products. Its offerings cater to a wide array of industries, including manufacturing, financial services, and the public sector, enabling organizations to effectively measure, manage, and predict their financial and operational performance. The company also maintains offices in the United Kingdom, France, Switzerland, and Italy.

Atlantic Broadband

Debt Financing in 2004
Atlantic Broadband, founded in 2003 and based in Quincy, Massachusetts, operates cable systems across several states including Pennsylvania, Florida, Maryland, West Virginia, Delaware, South Carolina, and New York. The company provides a range of services such as cable television video and programming, Wi-Fi for homes and small businesses, high-speed data services, home networking equipment, and support services. Additionally, Atlantic Broadband offers cable telephony services for residential subscribers, hosted voice services for businesses, and various advanced broadband services. The company also sells local advertising on satellite-delivered channels and provides equipment rental, installation, and reconnection services. Atlantic Broadband delivers its products through direct sales, telemarketing, web-based, and retail channels.

LipoScience

Series E in 2003
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

Fiberlink

Series C in 2003
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.

Innovative Spinal Technologies

Series A in 2003
Innovative Spinal Technologies is a spine technology company based in Mansfield, Massachusetts, established in 2002. The company specializes in the development of motion preservation and minimally invasive treatments for spinal disorders. Its product portfolio includes the AXIENT Dynamic Fixation system, a pedicle screw-based motion system, and the PARAMOUNT Lumbar Fusion System, designed for lumbar fusion procedures in various surgical approaches, including minimally invasive and open techniques. Additionally, the PARAMOUNT MIS Pedicle Screw System caters to both single and multi-level procedures, while the PARAMOUNT Open Pedicle Screw System is tailored for minimally invasive lumbar fusion. The PARAMOUNT VBR is specifically engineered for a minimally invasive transforaminal approach, reflecting the company’s commitment to advancing spinal care through innovative technologies.

Zilliant

Series B in 2002
Zilliant provides price optimization and management software tailored for manufacturing, distribution, high-tech, and industrial service companies. Their solutions enable businesses to analyze pricing strategies, optimize prices, manage price lists, and handle quoting and negotiation processes. Key offerings include the Zilliant Precision Pricing Suite (ZPPS), which integrates price segmentation, optimization science, analytics, and process automation. Additionally, Zilliant offers tools for deal management, price campaign management, and pricing information management. The company also provides deployment strategies, implementation methodologies, and educational services to support business and technical users. Founded in 1999, Zilliant is headquartered in Austin, Texas.

BEELINE Technologies

Venture Round in 2002
BEELINE Technologies is the global software partner for clients requiring integrated autonomous control and navigation technologies for land-based vehicles. Quality assured and agile, we develop integrated solutions across all industries. For more than 10 years, the company’s diverse and experienced teams have worked with original equipment manufacturers and technology organisations, to deliver flexible, leading-edge technology solutions for self-propelled, ground-based vehicles. BEELINE is proud of its pioneering spirit, and its innovative, autonomous solutions are used extensively around the world. BEELINE’s commitment to product innovation continues through its investment in sophisticated technology research and development programs that deliver outstanding solutions to our clients. BEELINE is in an exciting growth phase that continues to build value for its existing clients, whilst applying that experience, knowledge, and capability to new industries and technologies.

Confluent Surgical

Series C in 2002
Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

AnnuityNet

Series B in 2002
AnnuityNet is a supplier of on-demand software and e-commerce services to the insurance, financial, and healthcare industries.

IP Communications

Series C in 2002
Dallas-based IP Communications (IPC) has the most extensive broadband network in Texas, Missouri, Oklahoma and Kansas. IP Communications provides wide-area networking services to replace traditional private line, frame relay and ISDN with cost effective packet-based solutions. Our next-generation packet-switched network uses a redundant ATM backbone and advanced switching capabilities to provide high quality bundled communication services to all of our customers.

IntraLuminal Therapeutics

Venture Round in 2002
IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The company’s platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and men’s and women’s health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.

SoftSwitching Technologies

Series C in 2002
SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a comprehensive range of products, including battery-free DySC systems, intelligent I-Sense sensors that accurately detect and measure the duration of voltage sags, and a unique global notification network called Grid Alert, which reports power events. These products are designed to identify and rectify brief power disruptions, enhancing operational uptime and efficiency in manufacturing processes. By offering affordable and scalable solutions, SoftSwitching Technologies aims to improve power management for its clients across various sectors.

LaserComm

Series D in 2002
Lasercomm Inc was founded in 1998. The company's line of business includes providing telephone voice and data communications services. LaserComm is a privately held Israeli company. The company has developed a technology which established the foundation of a new breed of photonic components and modules for fiber optic networks. Based on its core competence, LaserComm aims to break new grounds in the field of dispersion management. The company develops products specifically designed to increase bandwidth, improve reliability, and reduce the cost of services provided by long-haul and ultra long-haul carriers.

Achillion Pharmaceuticals

Venture Round in 2002
Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Blue Bell, Pennsylvania, specializing in the discovery, development, and commercialization of small molecule drug therapies targeting immune system disorders. Its lead candidate, ACH-4471, is a factor D inhibitor currently undergoing Phase II clinical trials for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and C3 glomerulopathy. The company is also advancing other factor D inhibitors, including ACH-5228 and ACH-5548, both of which are in Phase I clinical trials for PNH and other complement-mediated diseases. Achillion has established license agreements with Ora, Inc. for the development of ACH-702 and with GCA Therapeutics, Ltd. for elvucitabine, a treatment for hepatitis B and HIV. Founded in 1998, Achillion operates as a subsidiary of Alexion Pharmaceuticals, Inc. Its focus is on advancing therapies that address disorders linked to the complement system, which plays a crucial role in the innate immune response.

Mesa Communications Group

Venture Round in 2002
Mesa Communications Group is a network of clustered community towers designed to accommodate wireless communication operators. It provides tower space to the wireless communications industry. The company develops a network of clustered community towers designed to accommodate wireless communication operators, including broadband wireless carriers, and FM and TV broadcasters, as well as paging, government, and other private land mobile radio operators. Mesa Communications Group was founded in 1999 and is based in Falls Church, Virginia.

Catalytic Solutions

Series C in 2002
Catalytic Solutions manufactures and distributes emissions control systems and catalytic products for commercial and industrial applications. It manufactures nanostructured catalysts at its main facility in Oxnard, California. The company’s products are most commonly applied to automobile, diesel engine, and energy markets. Catalytic Solutions has manufacturing facilities in Oxnard, California; Reno, Nevada; Thornhill, Canada; and Malmo, Sweden. Catalytic Solutions, Inc. operates as a subsidiary of Clean Diesel Technologies Inc.

DotCast

Series C in 2002
Dotcast, Inc. is a privately held company focused on developing a high-speed wireless broadband network that aims to deliver substantial amounts of rich media and digital content to consumers and businesses across the United States. The company specializes in broadband communications technology and offers digital data distribution products and services. By enabling cable operators to utilize their existing infrastructure, Dotcast provides solutions for both digital and analog broadcast signals. Additionally, the company offers terrestrial datacasting solutions that allow broadcasters and content providers to transmit high-capacity data streams over the air, leveraging the existing television infrastructure to create an ultra low-cost distribution channel for a wide range of industries.

R2 Technology

Venture Round in 2001
R2 Technology develops and commercializes computer-aided detection systems for the early-detection of breast cancer. R2 Technology pioneered the use of CAD for mammography in 1998 when the ImageChecker system became the first CAD system approved by the FDA for screening mammography. The company was founded in 1993 and is headquartered in Santa Clara, California. As of July 13, 2006, R2 Technology, Inc. operates as a subsidiary of Hologic Inc.

Intraspect Software

Venture Round in 2001
Intraspect Software is a U.S.-based company founded in 1995 that specializes in knowledge management and collaborative software solutions for enterprises. The company's offerings focus on improving inter-enterprise collaboration, particularly in complex industries such as financial services and high technology. Intraspect's products enable organizations to create shared communities and facilitate collaboration on strategic accounts and business processes. Its notable product, Intraspect 5.5, features architectural enhancements designed for inter-enterprise deployments, while the C-mail Services facilitate communication between users and the software. Intraspect Software aims to enhance communication and collaboration across functional, organizational, and geographic boundaries, streamlining interactions among cross-functional teams, customers, suppliers, and partners. The company was acquired by Vignette in 2003.

Standard BioTools

Series C in 2001
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.

Citadon

Venture Round in 2001
Citadon, established by Tawfik Hammound and headquartered in California, specializes in internet-based project collaboration solutions tailored to the engineering and construction industry. Its product suite includes CAFM Explorer, Collaboration Workspace, DocLeader, McLaren Enterprise, Fusion, and OPIDIS, catering to Architecture, Engineering, and Construction (AEC) firms, facilities managers, owner operations teams, and Engineering, Procurement, and Construction (EPC) companies across construction, oil and gas, life sciences, energy, and nuclear sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.